143
Participants
Start Date
December 4, 2020
Primary Completion Date
May 10, 2022
Study Completion Date
March 13, 2023
DLQI and PSO-TARGET QoL grid
At inclusion visit, and after 3 and 12 months, the patient will fill a patient questionnaire containing DLQI and PSO-TARGET QoL grid
Cliniques Universitaires Saint Luc - UCLouvain, Brussels
Private practice, Geel
Private practice, Genk
Private practice, Kalken
Centre Dermatologique du Roy, Lasne
Dermatology Maldegem, Maldegem
CHU Ambroise Paré, Mons
CHU UCL Namur - Sainte Elisabeth, Namur
Private practice, Namur
Private practice, Waregem
Chu de Rennes, Auray
Chru de Besancon - Hopital Jean Minjoz, Besançon
Polyclinique de Courlancy-Bezanes, Bezannes
Centre Hospitalier de Boulogne-sur-mer, Boulogne-sur-Mer
CHU de CAEN, Caen
Ch William Morey, Chalon-sur-Saône
Nouvel Hôpital Sud Francilien, Corbeil-Essonnes
Ch Annecy Genevois, Épagny
Hopital Jacques Monod, Montivilliers
Cide Azur, Nice
Ch Cote de Lumiere, Olonne-sur-Mer
Hopital Paris Saint-Joseph, Paris
Ch de Perpignan, Perpignan
CHU de Poitiers, Poitiers
Hôpital d'Instruction des armées SAINTE ANNE, Toulon
Hopital Larrey, Toulouse
CHRU de NANCY - BSM BRABOIS, Vandœuvre-lès-Nancy
Lead Sponsor
Collaborators (1)
LEO Pharma
INDUSTRY
Clinact
OTHER